Ligand-based modeling of semicarbazones and thiosemicarbazones derivatives as Cathepsin B, H, and L inhibitors: A multi-target approach

被引:6
|
作者
Pandey, Vandana [1 ]
Sharma, Kavita [1 ]
Raghav, Neera [1 ]
机构
[1] Kurukshetra Univ, Dept Chem, Kurukshetra 136119, Haryana, India
关键词
Cathepsin inhibitors; In-silico study; Mt-QSAR; Artificial neural network; Docking; ADME/tox; LYSOSOMAL CYSTEINE PROTEASES; NEURAL-NETWORKS; QSAR MODELS; DESIGN; VALIDATION; POTENT;
D O I
10.1016/j.molstruc.2022.132612
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
This work describes the development, validation, and comparison of three different multi-target artificial neural network models to explore quantitative structure-activity relationships (mt-QSAR) forin-silico design of compounds containing carbonyl and thiocarbonyl moiety, as inhibitors against the related cysteine proteases, cathepsin B, H, and L. The proposed three models are based on back propagation neural network (trained with LM and SCG algorithm) and radial basis neural network (RBNN). The validation of the model was carried out by using an external test set which showed (r (2) (ANN_LM) = 0.752, r (2) (ANN_SCG) = 0.661, r (2) (RBNN) = 0.45) for these mt-QSAR models. As per results, RBNN is good at the fitting stage but BPNN (LM) outperformed in predicting stage than the rest of the two. The applicability domain of the proposed models is evaluated by the leverage approach. Based on SAR outcome, some new inhibitors are also designed and their activities predicted using the best proposed model. In addition, molecular docking studies of the best selected inhibitors have been performed to determine the optimum binding conformation. Binding energy values are in accordance with inhibitory activity values. For the first time, molecular modeling studies are used to explore the bond rearrangement after ligandcathepsin interaction to display the interactions with amino acid residues of the receptor. The reported inhibitors also complied with Lipinski's rule of five. (C) 2022 Elsevier B.V. All rights reserved.
引用
收藏
页数:11
相关论文
共 47 条
  • [31] Machine learning-based q-RASAR approach for the in silico identification of novel multi-target inhibitors against Alzheimer's disease
    Kumar, Vinay
    Banerjee, Arkaprava
    Roy, Kunal
    Chemometrics and Intelligent Laboratory Systems, 2024, 245
  • [32] Ligand-based virtual screening, consensus molecular docking, multi-target analysis and comprehensive ADMET profiling and MD stimulation to find out noteworthy tyrosine kinase inhibitor with better efficacy and accuracy
    Rahman, Arifur
    Naheed, Nazmul Hasan
    Raka, Sabreena Chowdhury
    Qais, Nazmul
    Momen, A. Z. M. Ruhul
    ADVANCES IN TRADITIONAL MEDICINE, 2020, 20 (04) : 645 - 661
  • [33] Ligand-based virtual screening, consensus molecular docking, multi-target analysis and comprehensive ADMET profiling and MD stimulation to find out noteworthy tyrosine kinase inhibitor with better efficacy and accuracy
    Arifur Rahman
    Nazmul Hasan Naheed
    Sabreena Chowdhury Raka
    Nazmul Qais
    A. Z. M. Ruhul Momen
    Advances in Traditional Medicine, 2020, 20 : 645 - 661
  • [34] Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins (vol 21, pg 511, 2017)
    Speck-Planche, Alejandro
    Cordeiro, M. Natalia D. S.
    MOLECULAR DIVERSITY, 2017, 21 (03) : 511 - 523
  • [35] Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: An analysis in light of structure-based multi-molecular modeling evidences
    Adhikari, Nilanjan
    Banerjee, Suvankar
    Baidya, Sandip Kumar
    Ghosh, Balaram
    Jha, Tarun
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1251
  • [36] Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling
    Sagiru Hamza Abdullahi
    Adamu Uzairu
    Gideon Adamu Shallangwa
    Sani Uba
    Abdullahi Bello Umar
    Journal of the Egyptian National Cancer Institute, 35
  • [37] Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling
    Abdullahi, Sagiru Hamza
    Uzairu, Adamu
    Shallangwa, Gideon Adamu
    Uba, Sani
    Umar, Abdullahi Bello
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
  • [38] PTML Modeling for Alzheimer's Disease: Design and Prediction of Virtual Multi-Target Inhibitors of GSK3B, HDAC1, and HDAC6
    Kleandrova, Valeria V.
    Speck-Planche, Alejandro
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (19) : 1661 - 1676
  • [39] Discovery of phthalazino[1,2-b]-quinazolinone derivatives as multi-target HDAC inhibitors for the treatment of hepatocellular carcinoma via activating the p53 signal pathway
    Liu, Qingqing
    Zhang, Bin
    Wang, Yuanjiang
    Wang, Xinyi
    Gou, Shaohua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
  • [40] Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de] isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors
    Ferrari, Stefania
    Ingrami, Marco
    Soragni, Fabrizia
    Wade, Rebecca C.
    Costi, M. Paola
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 663 - 668